Increased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest pain

Heart

Volumn 91, Issue 9, 2005, Pages 1148-1153

  Birnie, David H ^a,b   Vickers, L E ^b   Hillis, W S ^c   Norrie, J ^d   Cobbe, S M ^b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 60 ANTIBODY; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 65 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASSAY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TEACHING HOSPITAL; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE DISEASE; AGED; ANGINA PECTORIS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHAPERONIN 60; ELECTROCARDIOGRAPHY; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 23944515730     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.040485     Document Type: Article

References (34)

1. Xu Q, Dietrich H, Steiner HJ, et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 1992;12:789-99.
2. Xu Q, Willeit J, Marosi M, et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 1993;341:255-9.
3. Xu Q, Luef G, Weimann S, et al. Staining of endothelial cells and macrophages in atherosclerotic lesions with human heat-shock protein-reactive antisera. Arterioscler Thromb 1993;13:1763-9.
4. Xu Q, Kleindienst R, Waitz W, et al. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to neat shock protein 65. J Clin Invest 1993;91:2693-702.
5. Xu Q, Schett G, Seitz CS, et al. Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ Res 1994;75:1078-85.
6. Xu Q, Kleindienst R, Schett G, et al. Regression of arteriosclerotic lesions induced by immunization with heat shock protein 65-containing material in normocholesterolemic, but not hypercholesterolemic, rabbits. Atherosclerosis 1996;123:145-55.
7. Birnie DH, Holme ER, McKay IC, et al. Association between antibodies to heat shock protein 65 and coronary atherosclerosis: possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J 1998;19:387-94.
8. Hoppichler F, Lechleitner M, Traweger C, et al. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 1996;126:333-8.
9. Huittinen T, Leinonen M, Tenkanen L, et al. Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation 2003;107:2566-70.
10. Prohaszka Z, Duba J, Horvath L, et al. Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. Eur J Clin Invest 2001;31:285-92.
11. Zhu J, Quyyumi AA, Rott D, et al. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 2001;103:1071-5.
12. Huittinen T, Leinonen M, Tenkanen L, et al. Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation 2003;107:2566-70.
13. Kiechl S, Egger G, Mayr M, et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001;103:1064-70.
14. Veres A, Fust G, Smieja M, et al. Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events. Circulation 2002;106:2775-80.
15. Xu Q, Kiechl S, Mayr M, et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 1999;100:1169-74.
16. Xu Q, Willeit J, Marosi M, et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 1993;341:255-9.
17. Birnie D, McKay IC, Veitch J, et al. Antimycobacterial hsp65 and rheumatoid factor titres in a population of normal twins: evidence of genetic control of rheumatoid factor. Clin Exp Immunol 1995;101:393-7.
18. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9.
19. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994;331:468-9.
20. Wick G, Schett G, Amberger A, et al. Is atherosclerosis an immunologically mediated disease? Immunol Today 1995;16:27-33.
21. Fong IW, Chiu B, Viira E, et al. Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques. J Infect Dis 2002;186:1469-73.
22. Mahdi OS, Horne BD, Mullen K, et al. Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease. Circulation 2002;106:1659-63.
23. Burian K, Kis Z, Virok D, et al. Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis. Circulation 2001;103:1503-8.
24. Hirono S, Dibrov E, Hurtado C, et al. Chlamvdia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60. Circ Res 2003;93:710-6.
25. Huittinen T, Leinonen M, Tenkanen I, et al. Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation 2003;107:2566-70.
26. Fong IW, Chiu B, Viira E, et al. Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques. J Infect Dis 2002;186:1469-73.
27. Kiechl S, Egger G, Mayr M, et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001;103:1064-70.
28. Gupta S, Knowlton AA. Cytosolic heat shock protein 60, hypoxia, and apoptosis. Circulation 2002;106:2727-33.
29. Stollberger C, Finsterer J. Atherosclerosis: infection-induced involvement of mitochondrial chaperonins [editorial]. Lancet 2003;362:1949-50.
30. Venner TJ, Gupta RS. Nucleotide sequence of mouse HSP60 (chaperonin, GroEL homolog) cDNA. Biochim Biophys Acta 1990;1087:336-8.
31. Ikonomidis I, Andreotti F, Economou E, et al. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999;100:793-8.
32. Feldman M, Jialal I, Devaraj S, et al. Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay. J Am Coll Cardiol 2001;37:2036-41.
33. Feng D, Tracy RP, Lipinska I, et al. Effect of short-term aspirin use on C-reactive protein. J Tnromb Thrombolysis 2000;9:37-41.
34. Ridker PM, Cushman M, Stampfer AAJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.